Annual Cash & Cash Equivalents
$45.29 M
-$1.06 M-2.28%
December 31, 2024
Summary
- As of March 10, 2025, CYRX annual cash & cash equivalents is $45.29 million, with the most recent change of -$1.06 million (-2.28%) on December 31, 2024.
- During the last 3 years, CYRX annual cash & cash equivalents has fallen by -$93.81 million (-67.44%).
- CYRX annual cash & cash equivalents is now -67.44% below its all-time high of $139.10 million, reached on December 31, 2021.
Performance
CYRX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$45.29 M
+$624.00 K+1.40%
December 31, 2024
Summary
- As of March 10, 2025, CYRX quarterly cash and cash equivalents is $45.29 million, with the most recent change of +$624.00 thousand (+1.40%) on December 31, 2024.
- Over the past year, CYRX quarterly cash and cash equivalents has stayed the same.
- CYRX quarterly cash and cash equivalents is now -72.04% below its all-time high of $161.99 million, reached on September 30, 2020.
Performance
CYRX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CYRX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.3% | 0.0% |
| 3 y3 years | -67.4% | 0.0% |
| 5 y5 years | -4.1% | 0.0% |
CYRX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -67.4% | +23.8% | -67.4% | +47.4% |
| 5 y | 5-year | -67.4% | +23.8% | -72.0% | +47.4% |
| alltime | all time | -67.4% | >+9999.0% | -72.0% | >+9999.0% |
Cryoport Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $45.29 M(-2.3%) | $45.29 M(+1.4%) |
| Sep 2024 | - | $44.66 M(-3.9%) |
| Jun 2024 | - | $46.46 M(-6.5%) |
| Mar 2024 | - | $49.66 M(+7.2%) |
| Dec 2023 | $46.35 M(+26.6%) | $46.35 M(-22.1%) |
| Sep 2023 | - | $59.47 M(-11.6%) |
| Jun 2023 | - | $67.31 M(+74.7%) |
| Mar 2023 | - | $38.54 M(+5.3%) |
| Dec 2022 | $36.59 M(-73.7%) | $36.59 M(+19.1%) |
| Sep 2022 | - | $30.72 M(-17.0%) |
| Jun 2022 | - | $37.03 M(-72.5%) |
| Mar 2022 | - | $134.45 M(-3.3%) |
| Dec 2021 | $139.10 M(+277.2%) | $139.10 M(+218.5%) |
| Sep 2021 | - | $43.68 M(-27.6%) |
| Jun 2021 | - | $60.36 M(-29.4%) |
| Mar 2021 | - | $85.49 M(+131.9%) |
| Dec 2020 | $36.87 M(-21.9%) | $36.87 M(-77.2%) |
| Sep 2020 | - | $161.99 M(+265.4%) |
| Jun 2020 | - | $44.33 M(-12.4%) |
| Mar 2020 | - | $50.62 M(+7.2%) |
| Dec 2019 | $47.23 M(+26.5%) | $47.23 M(+5.9%) |
| Sep 2019 | - | $44.59 M(-44.7%) |
| Jun 2019 | - | $80.64 M(+146.1%) |
| Mar 2019 | - | $32.77 M(-12.2%) |
| Dec 2018 | $37.33 M(+148.1%) | $37.33 M(+169.5%) |
| Sep 2018 | - | $13.85 M(-30.8%) |
| Jun 2018 | - | $20.01 M(+5.4%) |
| Mar 2018 | - | $18.99 M(+26.3%) |
| Dec 2017 | $15.04 M(+232.5%) | $15.04 M(-2.3%) |
| Sep 2017 | - | $15.40 M(+19.8%) |
| Jun 2017 | - | $12.85 M(-11.5%) |
| Mar 2017 | - | $14.53 M(+468.1%) |
| Dec 2016 | $4.52 M(+62.0%) | - |
| Sep 2016 | - | $2.56 M(-43.5%) |
| Jun 2016 | - | $4.53 M(+62.1%) |
| Mar 2016 | - | $2.79 M(-46.8%) |
| Mar 2016 | $2.79 M(+98.7%) | - |
| Dec 2015 | - | $5.25 M(-25.7%) |
| Sep 2015 | - | $7.06 M(+195.9%) |
| Jun 2015 | - | $2.39 M(+69.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | $1.41 M(+280.2%) | $1.41 M(+81.6%) |
| Dec 2014 | - | $773.90 K(+649.2%) |
| Sep 2014 | - | $103.30 K(-39.4%) |
| Jun 2014 | - | $170.50 K(-53.9%) |
| Mar 2014 | $369.60 K(-34.4%) | $369.60 K(+68.0%) |
| Dec 2013 | - | $220.00 K(-58.7%) |
| Sep 2013 | - | $532.50 K(+134.1%) |
| Jun 2013 | - | $227.50 K(-59.6%) |
| Mar 2013 | $563.10 K(-87.8%) | $563.10 K(-3.8%) |
| Dec 2012 | - | $585.10 K(-65.0%) |
| Sep 2012 | - | $1.67 M(-43.8%) |
| Jun 2012 | - | $2.97 M(-35.6%) |
| Mar 2012 | $4.62 M(-50.2%) | $4.62 M(+65.1%) |
| Dec 2011 | - | $2.80 M(-43.6%) |
| Sep 2011 | - | $4.95 M(-29.8%) |
| Jun 2011 | - | $7.06 M(-23.9%) |
| Mar 2011 | $9.28 M(+155.6%) | $9.28 M(+242.3%) |
| Dec 2010 | - | $2.71 M(-27.6%) |
| Sep 2010 | - | $3.75 M(+78.6%) |
| Jun 2010 | - | $2.10 M(-42.2%) |
| Mar 2010 | $3.63 M(+1353.1%) | $3.63 M(+460.8%) |
| Dec 2009 | - | $647.30 K(-42.2%) |
| Sep 2009 | - | $1.12 M(+101.3%) |
| Jun 2009 | - | $556.90 K(+122.9%) |
| Mar 2009 | $249.80 K(-88.8%) | $249.80 K(-67.8%) |
| Dec 2008 | - | $776.20 K(-36.3%) |
| Sep 2008 | - | $1.22 M(-44.3%) |
| Jun 2008 | - | $2.19 M(-1.9%) |
| Mar 2008 | $2.23 M(+743.8%) | $2.23 M(-20.0%) |
| Dec 2007 | - | $2.79 M(+1640.1%) |
| Sep 2007 | - | $160.30 K(-72.3%) |
| Jun 2007 | - | $578.50 K(+118.8%) |
| Mar 2007 | $264.40 K(+5525.5%) | $264.40 K(+974.8%) |
| Dec 2006 | - | $24.60 K(+132.1%) |
| Sep 2006 | - | $10.60 K(-0.9%) |
| Jun 2006 | - | $10.70 K(+127.7%) |
| Mar 2006 | $4700.00(-99.3%) | $4700.00(-88.6%) |
| Dec 2005 | - | $41.40 K(-84.8%) |
| Sep 2005 | - | $273.00 K(-33.9%) |
| Jun 2005 | - | $413.20 K |
| Mar 2005 | $720.20 K | - |
FAQ
- What is Cryoport annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Cryoport?
- What is Cryoport annual cash & cash equivalents year-on-year change?
- What is Cryoport quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Cryoport?
- What is Cryoport quarterly cash and cash equivalents year-on-year change?
What is Cryoport annual cash & cash equivalents?
The current annual cash & cash equivalents of CYRX is $45.29 M
What is the all time high annual cash & cash equivalents for Cryoport?
Cryoport all-time high annual cash & cash equivalents is $139.10 M
What is Cryoport annual cash & cash equivalents year-on-year change?
Over the past year, CYRX annual cash & cash equivalents has changed by -$1.06 M (-2.28%)
What is Cryoport quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CYRX is $45.29 M
What is the all time high quarterly cash and cash equivalents for Cryoport?
Cryoport all-time high quarterly cash and cash equivalents is $161.99 M
What is Cryoport quarterly cash and cash equivalents year-on-year change?
Over the past year, CYRX quarterly cash and cash equivalents has changed by $0.00 (0.00%)